KRISTEN FIBBIO: Open Payments
NPI 1316609340 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 7 payments from 7 companies in 2025. Trend: 2023 $3,865 · 2024 $929 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| BeiGene USA, Inc. | 1 | $150 |
| Astellas Pharma US Inc | 1 | $118 |
| Incyte Corporation | 1 | $111 |
| Janssen Biotech, Inc. | 1 | $84 |
| GENZYME CORPORATION | 1 | $76 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: BRUKINSA, Xospata, Niktimvo, RYBREVANT, CABLIVI, Enhertu, KISQALI.
Industry payments across FL — which companies pay providers there.
